With SR89 treatment, 72% of metastatic breast and prostate cancer patients reduced or stopped their opiates and/or analgesics – with relief lasting 3 months. Why aren’t they using it more?
Gan To Kagaku Ryoho. 2010 Oct;37(10):1868-1871.
[Pain Control for Bone Metastasis Using Radioactive Strontium.]
[Article in Japanese]
Yamaguchi K. abstract here
- 60 cases of metastatic cancer.
- Didn’t work much in lung cancer
- Worked well in breast and prostate cancer patients
- 72% improvement with stopped or reduced painkillers lasting 3 month
- Repeated doses could be used but decrease of hemoglobin, WBC, and platelets could be an issue
- Contraindicated in Rapidly progressive disease cases, radiculopathy cases, and soft tissue invasion.